ATE167982T1 - Diätzusammensetzungen und verfahren zur verwendung von gallsäure aktivierter lipase - Google Patents

Diätzusammensetzungen und verfahren zur verwendung von gallsäure aktivierter lipase

Info

Publication number
ATE167982T1
ATE167982T1 AT88310942T AT88310942T ATE167982T1 AT E167982 T1 ATE167982 T1 AT E167982T1 AT 88310942 T AT88310942 T AT 88310942T AT 88310942 T AT88310942 T AT 88310942T AT E167982 T1 ATE167982 T1 AT E167982T1
Authority
AT
Austria
Prior art keywords
methods
gallic acid
activated lipase
acid activated
lipase
Prior art date
Application number
AT88310942T
Other languages
English (en)
Inventor
Jordan J N Tang
Chi-Sun Wang
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of ATE167982T1 publication Critical patent/ATE167982T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1216—Other enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric
AT88310942T 1987-11-19 1988-11-18 Diätzusammensetzungen und verfahren zur verwendung von gallsäure aktivierter lipase ATE167982T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/122,410 US4944944A (en) 1987-11-19 1987-11-19 Dietary compositions and methods using bile salt-activated lipase

Publications (1)

Publication Number Publication Date
ATE167982T1 true ATE167982T1 (de) 1998-07-15

Family

ID=22402581

Family Applications (2)

Application Number Title Priority Date Filing Date
AT93203480T ATE197127T1 (de) 1987-11-19 1988-11-18 Verwendung von gallsäure-aktiviertem lipase als diätsupplement
AT88310942T ATE167982T1 (de) 1987-11-19 1988-11-18 Diätzusammensetzungen und verfahren zur verwendung von gallsäure aktivierter lipase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT93203480T ATE197127T1 (de) 1987-11-19 1988-11-18 Verwendung von gallsäure-aktiviertem lipase als diätsupplement

Country Status (8)

Country Link
US (1) US4944944A (de)
EP (2) EP0317355B1 (de)
JP (2) JP2592939B2 (de)
AT (2) ATE197127T1 (de)
DE (2) DE3856214T2 (de)
ES (2) ES2120402T3 (de)
GR (1) GR3035093T3 (de)
HK (2) HK1023031A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US5200183A (en) * 1987-11-19 1993-04-06 Oklahoma Medical Research Foundation Recombinant bile salt activated lipases
US5000975A (en) * 1988-12-29 1991-03-19 American Home Products Corporation Randomized palm oil fat composition for infant formulas
US5008120A (en) * 1989-07-21 1991-04-16 Snow Brand Milk Products Co., Ltd. Method of preparing iron-fortified beverage
US5173408A (en) * 1989-11-13 1992-12-22 Lange Louis George Iii Mammalian pancreatic cholesterol esterase
JP2808166B2 (ja) * 1990-04-26 1998-10-08 雪印乳業株式会社 鉄強化飲料の製造方法
US5186961A (en) * 1991-03-15 1993-02-16 North Carolina State University Method and composition for maintaining animals on a keratin-containing diet
US5169666A (en) * 1991-11-14 1992-12-08 The United States Of America As Represented By The Secretary Of Agriculture Preparation of simulated human milk protein by low temperature microfiltration
US5902617A (en) * 1992-05-19 1999-05-11 Pabst; Patrea L. Enzyme supplemented baby formula
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
US5460812A (en) * 1992-06-22 1995-10-24 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
US5821226A (en) * 1994-12-01 1998-10-13 Oklahoma Medical Research Foundation BAL C-tail drug delivery molecules
US5696087A (en) * 1994-12-01 1997-12-09 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5681819A (en) * 1994-12-01 1997-10-28 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US6342218B1 (en) 1997-02-14 2002-01-29 Oklahoma Medical Research Foundation Method for treatment of SLE
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
SK287687B6 (sk) * 1996-12-06 2011-06-06 Aventis Pharmaceuticals Inc. Izolovaný polypeptid kódovaný génom podobným génu pre lipázu, prostriedok majúci fosfolipázovú účinnosť, farmaceutický prostriedok, antigénny fragment a izolovaná nukleová kyselina, biologicky aktívny prostriedok, vektor, rekombinovaná hostiteľská bunka, prostriedok využiteľný na transfekáciu cieľovej bunky, spôsob výroby polypeptidu a polypeptid takto vyrobený, protilátka, hybridomná bunka, spôsob in vitro sceeningu, spôsob in vitro enzymatickej hydrolýzy, použitie polypeptidu a protilátky a
EP1065936B1 (de) 1998-03-23 2009-08-05 General Mills, Inc. Verkapselung von komponenten in essbaren produkten
US7201923B1 (en) 1998-03-23 2007-04-10 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
ATE413889T1 (de) * 1998-06-05 2008-11-15 Nutrinia Ltd Insulin angereichertes säuglingsnährpräparat
US6399090B1 (en) * 1998-06-05 2002-06-04 Insotech Ltd. Insulin supplemented infant formula
AU5032600A (en) * 1999-05-19 2001-12-03 Barnes-Jewish Hospital Enhanced triglyceride digestion in a deficiency of bile salts
EP1059041A1 (de) * 1999-06-07 2000-12-13 Universiteit Gent Kombinierte Verwendung von Triglyceriden mit mittelkettigen Fettsäuren und exogenen lipolytischen Enzymen als Futterzusätze
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
US7381404B2 (en) * 2002-07-02 2008-06-03 The Regents Of The University Of California Treatment for dry macular degeneration
US7431986B2 (en) 2002-07-24 2008-10-07 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
EP2853593B1 (de) 2003-03-07 2017-10-04 DSM IP Assets B.V. Hydrolasen, Nucleinsäuren zur Codierung davon sowie Verfahren zur Herstellung und Verwendung davon
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
US8071089B2 (en) * 2005-11-01 2011-12-06 Bio-Cat, Inc. Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency
WO2007092314A2 (en) 2006-02-02 2007-08-16 Verenium Corporation Esterases and related nucleic acids and methods
AR059692A1 (es) * 2007-03-01 2008-04-23 Adriana Fernandez Alimento de alto contenido calorico y de facil digestion
US8153391B2 (en) 2008-08-29 2012-04-10 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
US8357503B2 (en) 2008-08-29 2013-01-22 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
US8198062B2 (en) 2008-08-29 2012-06-12 Dsm Ip Assets B.V. Hydrolases, nucleic acids encoding them and methods for making and using them
RU2013123056A (ru) * 2010-10-21 2014-11-27 Сведиш Орфан Биовитрум Аб (Пабл) Способ повышения всасывания ненасыщенных жирных кислот у грудных детей
JP5850940B2 (ja) 2010-10-21 2016-02-03 スウェディッシュ オーファン バイオビトラム パブリーク アクチエボラグ ヒト乳児の発育速度を増大させる方法
KR102073083B1 (ko) 2012-02-17 2020-02-04 알크레스타, 인크. 식이 지방산 수요를 공급하기 위한 방법들, 조성물들 및 디바이스들
GB201501081D0 (en) 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
US10258590B2 (en) 2015-10-14 2019-04-16 Alcresta Therapeutics, Inc. Enteral feeding device and related methods of use
ES2957891T3 (es) 2016-03-24 2024-01-29 Elgan Pharma Ltd Uso de insulina para promover el vaciamiento gástrico
US11045396B2 (en) 2017-08-17 2021-06-29 Alcresta Therapeutics, Inc. Devices and methods for the supplementation of a nutritional formula

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA662815A (en) * 1963-05-07 G. Farnham Merle Treatment for "scours" in mammals
US3256150A (en) * 1964-04-20 1966-06-14 Dairyland Food Lab Method for treating malabsorption syndrome
US3991180A (en) * 1972-03-06 1976-11-09 Rohm And Haas Company Stabilization of internally administered pancreatic lipase
JPS5017559B2 (de) * 1972-09-20 1975-06-21
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
DE2638089C2 (de) * 1976-08-24 1985-04-25 Degussa Ag, 6000 Frankfurt Lipase-Präparate mit verbesserter Wirkung
GB1571877A (en) * 1978-04-24 1980-07-23 Meito Sangyo Kk Microbial lipase and its preparation
JPS6047858B2 (ja) * 1978-09-20 1985-10-24 田村 輝 温浴用水製造装置
DE2923279B1 (de) * 1979-06-08 1980-11-20 Kali Chemie Pharma Gmbh Verfahren zur Herstellung von Pankreatin-Pellets
EP0188067B1 (de) * 1985-01-09 1992-05-27 Genencor, Inc. Überführung von exogenen Stoffen in Käsebruch
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase

Also Published As

Publication number Publication date
EP0317355A3 (de) 1991-07-17
JPH06315347A (ja) 1994-11-15
DE3856214T2 (de) 1998-12-17
ES2120402T3 (es) 1998-11-01
DE3856435D1 (de) 2000-11-30
ATE197127T1 (de) 2000-11-15
JPH01231848A (ja) 1989-09-18
DE3856214D1 (de) 1998-08-13
US4944944A (en) 1990-07-31
EP0605913A1 (de) 1994-07-13
DE3856435T2 (de) 2001-03-29
EP0317355A2 (de) 1989-05-24
ES2152941T3 (es) 2001-02-16
GR3035093T3 (en) 2001-03-30
EP0317355B1 (de) 1998-07-08
JP2592939B2 (ja) 1997-03-19
HK1012213A1 (en) 1999-07-30
HK1023031A1 (en) 2000-08-25
EP0605913B1 (de) 2000-10-25

Similar Documents

Publication Publication Date Title
ATE167982T1 (de) Diätzusammensetzungen und verfahren zur verwendung von gallsäure aktivierter lipase
US6699496B1 (en) Enzyme in a dosage form for oral use in mammals, enzyme-containing food material and method for administering the enzyme in a dosage form
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
JPS6466118A (en) Free fatty acid for treating or preventing chronic articular rheumatism
DE3873800T2 (de) Zusammensetzungen zur behandlung von hypercholesterinaemie.
DE3570362D1 (en) Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity
JPS56154951A (en) Cocconut fat substitute and method
ATE210977T1 (de) Pharmazeutische zusammensetzung enthaltend ein alkanoyl-l-carnitin in kombination mit einer polyungesättigten fettsäure der omega-3-serie zur verhütung und behandlung von störungen des fettstoffwechsels
IT8449063A1 (it) Composizione di acidi grassi combinati per abbassare livelli di colesterolo e trigliceridi nel sangue e metodo per separare detti acidi grassi da loro sorgenti
US20110223246A1 (en) Docosahexaenoic acid bound in phospholipids and method of recovering same from a natural source
ATE212194T1 (de) Nahrungsprodukt zur behandlung der ulzerativen kolitis sowie verwendung desselben
SE8701847D0 (sv) Etliga fetter
ATE61051T1 (de) Substituierte pyrimidinamide von oelsaeure oder linolsaeure als inhibitoren von acyl-coa cholesterin-acyltransferase.
ATE13072T1 (de) Verfahren zur behandlung eines speiseoels.
Borel et al. Gastric lipase: evidence of an adaptive response to dietary fat in the rabbit
DE3878812D1 (de) Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
GR3007351T3 (de)
DE69813600D1 (de) Verfahren zur erhöhung der konzentration von konjugierter linolsäure in milch und/oder fettgewebe eines wiederkäuers
Suttie et al. Fat utilization in the fluoride-fed rat
Blaton et al. The human plasma lipids and lipoproteins under influence of EPL-therapy
EP0198804A3 (de) Diätetische Zusammensetzung und Verfahren zu ihrer Herstellung
SE8800101D0 (sv) Anvendning av essentiella fettsyror for framstellning av ett preparat for behandling av eksem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time